DK1030852T3 - Oxazolidinonderivater og farmaceutiske præparater - Google Patents

Oxazolidinonderivater og farmaceutiske præparater

Info

Publication number
DK1030852T3
DK1030852T3 DK98956200T DK98956200T DK1030852T3 DK 1030852 T3 DK1030852 T3 DK 1030852T3 DK 98956200 T DK98956200 T DK 98956200T DK 98956200 T DK98956200 T DK 98956200T DK 1030852 T3 DK1030852 T3 DK 1030852T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
organisms
oxazolidinone derivatives
compound
formula
Prior art date
Application number
DK98956200T
Other languages
Danish (da)
English (en)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1030852T3 publication Critical patent/DK1030852T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98956200T 1997-11-12 1998-10-30 Oxazolidinonderivater og farmaceutiske præparater DK1030852T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12
PCT/US1998/022639 WO1999024428A1 (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1030852T3 true DK1030852T3 (da) 2003-12-22

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956200T DK1030852T3 (da) 1997-11-12 1998-10-30 Oxazolidinonderivater og farmaceutiske præparater

Country Status (21)

Country Link
US (1) US5998406A (enExample)
EP (1) EP1030852B1 (enExample)
JP (1) JP2001522849A (enExample)
KR (1) KR20010031953A (enExample)
CN (1) CN1154644C (enExample)
AT (1) ATE250054T1 (enExample)
AU (1) AU739055B2 (enExample)
BR (1) BR9813985A (enExample)
CA (1) CA2303959A1 (enExample)
DE (1) DE69818294T2 (enExample)
DK (1) DK1030852T3 (enExample)
ES (1) ES2207010T3 (enExample)
HU (1) HUP0100470A3 (enExample)
IL (1) IL136062A (enExample)
NO (1) NO317291B1 (enExample)
NZ (1) NZ504503A (enExample)
PT (1) PT1030852E (enExample)
RU (1) RU2215740C2 (enExample)
SK (1) SK284577B6 (enExample)
TR (1) TR200001330T2 (enExample)
WO (1) WO1999024428A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1082323A2 (en) 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
MXPA05001558A (es) 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
MXPA06002188A (es) * 2003-08-25 2006-04-27 Warner Lambert Co Nuevos compuestos antimicrobianos de ariloxazolidinona.
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2006056877A2 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
CA2610978A1 (en) 2005-06-29 2007-01-04 Pharmacia & Upjohn Company Llc Homomorpholine oxazolidinones as antibacterial agents
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
CN101460495B (zh) 2006-03-31 2013-08-14 财团法人乙卯研究所 具有杂环的化合物
EP2669283A1 (en) 2007-10-02 2013-12-04 Shionogi&Co., Ltd. Oxazolidinone derivative having 7-membered hetero ring
US20130296569A1 (en) 2010-11-03 2013-11-07 Vijaykumar Jagdishwar Patil Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ATE95176T1 (de) * 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ES2157934T3 (es) * 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
EP0610265B1 (en) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
NZ274966A (en) * 1993-11-22 1998-01-26 Upjohn Co Substituted-hydroxyacetyl piperazine phenyl oxazolidinone derivatives, use in pharmaceutical compositions
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
PT1030852E (pt) 2004-02-27
BR9813985A (pt) 2000-09-26
NO20002434L (no) 2000-05-11
CN1271358A (zh) 2000-10-25
KR20010031953A (ko) 2001-04-16
CA2303959A1 (en) 1999-05-20
DE69818294D1 (de) 2003-10-23
ATE250054T1 (de) 2003-10-15
HUP0100470A2 (hu) 2002-05-29
JP2001522849A (ja) 2001-11-20
WO1999024428A1 (en) 1999-05-20
SK6182000A3 (en) 2000-12-11
EP1030852A1 (en) 2000-08-30
EP1030852B1 (en) 2003-09-17
TR200001330T2 (tr) 2000-11-21
NO317291B1 (no) 2004-10-04
RU2215740C2 (ru) 2003-11-10
AU739055B2 (en) 2001-10-04
NO20002434D0 (no) 2000-05-11
DE69818294T2 (de) 2004-07-08
ES2207010T3 (es) 2004-05-16
SK284577B6 (sk) 2005-07-01
IL136062A (en) 2004-02-08
IL136062A0 (en) 2001-05-20
HK1030373A1 (en) 2001-05-04
CN1154644C (zh) 2004-06-23
NZ504503A (en) 2002-10-25
HUP0100470A3 (en) 2002-08-28
AU1277899A (en) 1999-05-31
US5998406A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
NO20002434D0 (no) Oksazolidinonderivater og farmasøytiske preparater
MX9708627A (es) Oxazolidinonas de diazinilo y carbazinilo espirociclicas y biciclicas.
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
TR199801282T2 (xx) Mutilin'in karbamoiloksi t�revleri ve antibakteriyel olarak kullan�m�.
DE69714418D1 (de) Azolylpiperazinylphenyloxazolidinone als antimikrobielle mittel
ATE239376T1 (de) Antimikrobielle zusammensetzung.
RU94046011A (ru) Оксазолидиноновые антимикробные соединения, содержащие замещенные диазиновые части, способ лечения микробных инфекций
CO5031285A1 (es) Triarilimidazoles
GB9801690D0 (en) Therapeutic agents
FI950309A0 (fi) Proliiniamidijohdannaisia
DE69532039D1 (de) Isoxazole
FI943142A0 (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
WO2001003685A3 (en) Novel prodrugs for antimicrobial amidines
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
NZ309151A (en) a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
NZ333926A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
ATE205505T1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
DE60005517D1 (de) Kaliumkanal-blockierende mittel
MY122570A (en) Benzamide derivatives and drugs containing the same
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
PT740657E (pt) 4-aril-isoindois com actividade analgesica